Compare TACT & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TACT | NMTC |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.7M | 29.2M |
| IPO Year | 1996 | 2010 |
| Metric | TACT | NMTC |
|---|---|---|
| Price | $4.88 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.00 | ★ $11.90 |
| AVG Volume (30 Days) | 21.9K | ★ 49.4K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.88 | 80.43 |
| EPS | ★ 0.07 | N/A |
| Revenue | N/A | ★ $9,097,692.00 |
| Revenue This Year | $10.36 | N/A |
| Revenue Next Year | N/A | $31.90 |
| P/E Ratio | $70.14 | ★ N/A |
| Revenue Growth | N/A | ★ 163.47 |
| 52 Week Low | $3.06 | $0.55 |
| 52 Week High | $6.02 | $5.40 |
| Indicator | TACT | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 19.03 |
| Support Level | $4.62 | $0.67 |
| Resistance Level | $5.48 | $3.41 |
| Average True Range (ATR) | 0.26 | 0.25 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 12.98 | 3.15 |
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.